- Trends of low-grade serous ovarian carcinoma in the United States
-
Matsuo K, Machida H, Grubbs BH, Sood AK, Gershenson DM
- KMID: 2395242
- J Gynecol Oncol.
- 2018 Jan;29(1):e15.
- doi: 10.3802/jgo.2018.29.e15
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Quality and quantity metrics of pelvic lymph node metastasis and risk of para-aortic lymph node metastasis in stage IB–IIB cervical cancer
-
Matsuo K, Grubbs BH, Mikami M
- KMID: 2395237
- J Gynecol Oncol.
- 2018 Jan;29(1):e10.
- doi: 10.3802/jgo.2018.29.e10
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Epidemiology of gynecologic cancers in China
-
Jiang X, Tang H, Chen T
- KMID: 2395234
- J Gynecol Oncol.
- 2018 Jan;29(1):e7.
- doi: 10.3802/jgo.2018.29.e7
Cancer has become a major disease burden across the globe. It was estimated that 4.29 million new incident cases and 2.81 million death cases of cancer would occur in 2015... -
- CITED
-
- Close
- SHARE
-
- Close
- Baseline risk of recurrence in stage I–II endometrial carcinoma
-
Sasada S, Yunokawa M, Takehara Y, Ishikawa M, Ikeda S, Kato T, Tamura K
- KMID: 2395236
- J Gynecol Oncol.
- 2018 Jan;29(1):e9.
- doi: 10.3802/jgo.2018.29.e9
OBJECTIVE: Though there are no evidences that postoperative therapy improves overall survival (OS) in stage I–II endometrial carcinoma, many women receive postoperative radiation or chemotherapy. This study aimed to investigate... -
- CITED
-
- Close
- SHARE
-
- Close
- Impact of lymph node ratio on survival in stage III ovarian high-grade serous cancer: a Turkish Gynecologic Oncology Group study
-
Ayhan A, Ozkan NT, Sarı ME, Celik H, Dede M, Akbayır O, Güngördük K, Şahin H, Haberal A, Güngör T, Arvas M, Meydanlı
- KMID: 2395239
- J Gynecol Oncol.
- 2018 Jan;29(1):e12.
- doi: 10.3802/jgo.2018.29.e12
OBJECTIVE: The purpose of this study was to investigate the prognostic value of lymph node ratio (LNR) in patients with stage III ovarian high-grade serous carcinoma (HGSC). METHODS: A multicenter, retrospective... -
- CITED
-
- Close
- SHARE
-
- Close
- Robotic single site radical hysterectomy plus pelvic lymphadenectomy in gynecological cancers
-
Vizza E, Chiofalo B, Cutillo G, Mancini E, Baiocco E, Zampa A, Bufalo A, Corrado G
- KMID: 2395229
- J Gynecol Oncol.
- 2018 Jan;29(1):e2.
- doi: 10.3802/jgo.2018.29.e2
OBJECTIVE: To evaluate the feasibility and the safety of robotic single-site radical hysterectomy (RSSRH) plus pelvic lymphadenectomy (PL) in endometrial or cervical cancer. METHODS: Patients with endometrial cancer (EC) International Federation... -
- CITED
-
- Close
- SHARE
-
- Close
- Risk stratification models for para-aortic lymph node metastasis and recurrence in stage IB–IIB cervical cancer
-
Matsuo K, Shimada M, Saito T, Takehara K, Tokunaga H, Watanabe Y, Todo Y, Morishige , Mikami M, Sugiyama T
- KMID: 2395238
- J Gynecol Oncol.
- 2018 Jan;29(1):e11.
- doi: 10.3802/jgo.2018.29.e11
OBJECTIVE: To examine the surgical-pathological predictors of para-aortic lymph node (PAN) metastasis at radical hysterectomy, and for PAN recurrence among women who did not undergo PAN dissection at radical hysterectomy. METHODS:... -
- CITED
-
- Close
- SHARE
-
- Close
- Mutational analysis of KRAS and its clinical implications in cervical cancer patients
-
Jiang W, Xiang L, Pei X, He T, Shen X, Wu X, Yang H
- KMID: 2395231
- J Gynecol Oncol.
- 2018 Jan;29(1):e4.
- doi: 10.3802/jgo.2018.29.e4
OBJECTIVE: The predictive and prognostic role of KRAS mutations in cervical cancer remains inconclusive. The aim of this study was to explore the clinicopathological and prognostic relevance of KRAS mutations... -
- CITED
-
- Close
- SHARE
-
- Close
- Role of lymphadenectomy in intermediate-risk endometrial cancer: a matched-pair study
-
Coronado P, Rychlik A, MartÃnez-Maestre MA, Baquedano , Fasero M, GarcÃa-Arreza A, Morales S, Lubian DM, Zapardiel
- KMID: 2395228
- J Gynecol Oncol.
- 2018 Jan;29(1):e1.
- doi: 10.3802/jgo.2018.29.e1
OBJECTIVE: To assess the impact of lymph node dissection (LND) on morbidity, survival, and cost for intermediate-risk endometrial cancers (IREC). METHODS: A multicenter retrospective cohort of 720 women with IREC (endometrioid... -
- CITED
-
- Close
- SHARE
-
- Close
- Pazopanib monotherapy in the treatment of pretreated, metastatic uterine sarcoma: a single-center retrospective study
-
Kim HJ, Kim Y, Lee SJ, Lee J, Park SH
- KMID: 2395230
- J Gynecol Oncol.
- 2018 Jan;29(1):e3.
- doi: 10.3802/jgo.2018.29.e3
OBJECTIVE: In the treatment of metastatic soft tissue sarcoma (STS), pazopanib is considered a standard treatment after failure of chemotherapy. We retrospectively investigated outcomes of pazopanib in patients with metastatic... -
- CITED
-
- Close
- SHARE
-
- Close
- Survival benefit of patients with early-stage ovarian carcinoma treated with paclitaxel chemotherapeutic regimens
-
Chen CA, Chiang CJ, Chen YY, You SL, Hsieh SF, Tang CH, Cheng WF
- KMID: 2395243
- J Gynecol Oncol.
- 2018 Jan;29(1):e16.
- doi: 10.3802/jgo.2018.29.e16
OBJECTIVE: Adjuvant chemotherapy was introduced in patients with early-stage ovarian cancer (OC). The benefit of standard chemotherapeutic regimens including taxane has not been established. METHODS: Patients with early-stage OC from the... -
- CITED
-
- Close
- SHARE
-
- Close
- Oncologic outcomes of adjuvant chemotherapy alone after radical surgery for stage IB–IIA cervical cancer patients
-
Lee KB, Kim YS, Lee JM
- KMID: 2395232
- J Gynecol Oncol.
- 2018 Jan;29(1):e5.
- doi: 10.3802/jgo.2018.29.e5
OBJECTIVE: To evaluate the oncologic outcomes of adjuvant chemotherapy (CT) alone after radical surgery. METHODS: We retrospectively reviewed the medical records of patients who underwent type C radical hysterectomy and pelvic... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical outcomes and risk of recurrence among patients with vaginal intraepithelial neoplasia: a comprehensive analysis of 576 cases
-
Kim MK, Lee IH, Lee KH
- KMID: 2395233
- J Gynecol Oncol.
- 2018 Jan;29(1):e6.
- doi: 10.3802/jgo.2018.29.e6
OBJECTIVE: To evaluate the clinical outcomes of vaginal intraepithelial neoplasia (VAIN) and to assess the risk of recurrence and progression to invasive vaginal carcinoma. METHODS: A retrospective review of the clinicopathologic... -
- CITED
-
- Close
- SHARE
-
- Close
- The feasibility of detecting endometrial and ovarian cancer using DNA methylation biomarkers in cervical scrapings
-
Chang CC, Wang HC, Liao YP, Chen YC, Weng YC, Yu MH, Lai HC
- KMID: 2395244
- J Gynecol Oncol.
- 2018 Jan;29(1):e17.
- doi: 10.3802/jgo.2018.29.e17
OBJECTIVE: We hypothesized that DNA methylation of development-related genes may occur in endometrial cancer (EC)/ovarian cancer (OC) and may be detected in cervical scrapings. METHODS: We tested methylation status by quantitative... -
- CITED
-
- Close
- SHARE
-
- Close
- Prognostic significance of normal-sized ovary in advanced serous epithelial ovarian cancer
-
Paik ES, Kim JH, Kim TJ, Lee JW, Kim BG, Bae DS, Choi CH
- KMID: 2395240
- J Gynecol Oncol.
- 2018 Jan;29(1):e13.
- doi: 10.3802/jgo.2018.29.e13
OBJECTIVE: We compared survival outcomes of advanced serous type epithelial ovarian cancer (EOC) patients with normal-sized ovaries and enlarged-ovarian tumors by propensity score matching analysis. METHODS: The medical records of EOC... -
- CITED
-
- Close
- SHARE
-
- Close
- Are vaginal swabs comparable to cervical smears for human papillomavirus DNA testing?
-
Coorevits , Traen A, Bingé L, Van Dorpe , Praet M, Boelens J, Padalko E
- KMID: 2395235
- J Gynecol Oncol.
- 2018 Jan;29(1):e8.
- doi: 10.3802/jgo.2018.29.e8
OBJECTIVE: Human papillomavirus (HPV) testing is widely incorporated into cervical cancer screening strategies. Current screening requires pelvic examination for cervical sampling, which may compromise participation. The acceptance could be raised... -
- CITED
-
- Close
- SHARE
-
- Close
- Prevalence of human papillomavirus genotypes and precancerous cervical lesions in a screening population in the Republic of Korea, 2014–2016
-
Ouh YT, Min KJ, Cho HW, Ki M, Oh JK, Shin SY, Hong JH, Lee JK
- KMID: 2395241
- J Gynecol Oncol.
- 2018 Jan;29(1):e14.
- doi: 10.3802/jgo.2018.29.e14
OBJECTIVE: Knowledge regarding the prevalence and distribution of human papillomavirus (HPV) genotyping in healthy women is important in establishing strategies for cervical cancer screening and HPV vaccination. METHODS: A total of... -
- CITED
-
- Close
- SHARE
-
- Close
